CF PHARMTECH (02652) spent HK$418,700 to repurchase 18,500 shares on April 20th.
Changfeng Pharmaceutical (02652) announced that on April 20, 2026, the company spent 418,700 Hong Kong dollars to repurchase 18,500 shares at a repurchase price of 22.48-22.86 Hong Kong dollars per share.
CF PHARMTECH (02652) announced that on April 20, 2026, the company purchased 18,500 shares at a cost of HK$418,700, with a repurchase price of HK$22.48-22.86 per share.
Related Articles
US Stock Market Move | Collaborating with NVIDIA Corporation to expand edge AI applications, BlackBerry Limited (BB.US) soared more than 14% in early trading.
.png)
US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%
The resurgence of tariffs clouds the prospects of the industrial sector, and the "top students" of the US stock market face a major performance test.
US Stock Market Move | Collaborating with NVIDIA Corporation to expand edge AI applications, BlackBerry Limited (BB.US) soared more than 14% in early trading.
US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%
The resurgence of tariffs clouds the prospects of the industrial sector, and the "top students" of the US stock market face a major performance test.
RECOMMEND
Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026
Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026
Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026
